Navigation Links
TriLink BioTechnologies Awards Keck Science Department ResearchReward

SAN DIEGO, March 7, 2013 /PRNewswire/ -- TriLink BioTechnologies, Inc. (TriLink, has granted Dr. Aaron Leconte of the WM Keck Science Department of Claremont McKenna , Pitzer and Scripps Colleges a ResearchReward for mutant polymerase research.

"The use of DNA biotechnologies is often limited by which DNA polymerases recognize which modified nucleotide analogs," stated Dr. Leconte. "In my lab, we are working on discovering DNA polymerases with novel substrate recognition to expand the usefulness of modified nucleotides.  TriLink is one of the leaders in the synthesis of high-quality, novel nucleotide analogs, and this ResearchRewards grant enables us to work on a significantly more diverse set of nucleotide analogs," concluded Dr. Leconte.

"We are pleased that TriLink's modified nucleotide analogs and custom oligonucleotides help advance directed enzyme evolution," commented Richard Hogrefe , CEO of TriLink. "TriLink continues to expand its portfolio of nucleotide analogs to support researchers like Dr. Leconte, as they push the envelope of science."

TriLink has been proud to support research and education with its ResearchReward Program, since the program's inception in 2002. Over 35 grants have been awarded for research including nucleotide selectivity of error prone RNA viral polymerases, PCR primer design for undergraduate teaching and research, CleanAmp™ Primers for detection of mRNA expression and DNA repair studies of cross-linked DNA.

About TriLink's ResearchRewards Program
TriLink offers ResearchRewards to help offset the cost of nucleic acid-based products to support educators and researchers. Applicants will be notified of the review results within 2 months. To download an application or learn more visit

About TriLink
TriLink manufactures custom oligonucleotides, modified nucleoside triphosphates and CleanAmp™ PCR products for the diagnostic and OEM markets. In addition, custom chemistry, long RNA transcript synthesis and contract research services and ISO/QSR compliant cGMP production facilities are offered. TriLink's solutions help advance drug discovery and biomedical research. Founded in 1996, TriLink is a privately held firm based in San Diego, California and employs approximately 50 scientists and other professionals. For more information about the firm and products, visit our web site at

Angela Tenenini

SOURCE TriLink BioTechnologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. OPX Biotechnologies Selected as Innovation Pioneer at IHS CERAWeek
2. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
3. Medical Marijuana, Inc. Portfolio Company CanChew BioTechnologies Inc. Updates and Expands Free Product Trial
4. Lifeline Biotechnologies Receives Patent for Methods to Collect and Analyze Breast Thermal Data to Determine Suspect Conditions
5. Leading Scientists to Debate Views on Rejuvenation Biotechnologies
6. Young Pathologists Receive Awards for Research
7. National Non-Profit Awards Audio Conferencing to SoundConnect
8. Brain Research Foundation 2013 Scientific Innovations Awards To Dr. Jean Hebert and Dr. Brian Litt
9. Nerium Recaps the 44th Annual NAACP Image Awards
10. Molecular Medicine Awards 1st Annual Ross Prize to NYU Researcher
11. Taylor-Wharton CryoScience 'Partners For Life' Awards Liquid Nitrogen Freezer to Comprehensive Cancer Center at University of Alabama at Birmingham
Post Your Comments:
(Date:11/24/2015)... ... November 24, 2015 , ... International Society for Pharmaceutical Engineering ... premier annual events for pharmaceutical manufacturing: 2015 Annual Meeting. The conference took place ... the largest number of attendees in more than a decade. , “The ...
(Date:11/24/2015)... November 24, 2015 --> ... research report "Oligonucleotide Synthesis Market by Product & Services ... Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, ... MarketsandMarkets, the market is expected to reach USD 1,918.6 ... at a CAGR of 10.1% during the forecast period. ...
(Date:11/24/2015)... SHPG ) announced today that Jeff ... 27 th Annual Healthcare Conference in New York ... a.m. EST (1:30 p.m. GMT). --> SHPG ) announced ... in the Piper Jaffray 27 th Annual Healthcare Conference in ... 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - ... "Company") announced today that the remaining 11,000 post-share ... Share Purchase Warrants (the "Series B Warrants") subject ... were exercised on November 23, 2015, which will ... Shares.  After giving effect to the issuance of ...
Breaking Biology Technology:
(Date:11/20/2015)... 20, 2015 NXTD ) ("NXT-ID" ... the growing mobile commerce market and creator of the ... , was recently interviewed on The RedChip Money ... this weekend on Bloomberg Europe , Bloomberg Asia, ... --> NXTD ) ("NXT-ID" or the "Company"), a ...
(Date:11/19/2015)... , Nov. 19, 2015  Based on its in-depth ... Sullivan recognizes BIO-key with the 2015 Global Frost & ... Frost & Sullivan presents this award to the company ... to the needs of the market it serves. The ... meets and expands on customer base demands, the overall ...
(Date:11/19/2015)... NEW YORK , Nov. 19, 2015  Although ... the market is dominated by a few companies, according ... Qiagen. These companies own 51% of the market share of ... report, The World Market for Molecular Diagnostic ... "The market is still controlled by one ...
Breaking Biology News(10 mins):